Gregory Costain1, Anath C Lionel2, Lucas Ogura3, Christian R Marshall4, Stephen W Scherer2, Candice K Silversides5, Anne S Bassett6. 1. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Medical Genetics Residency Training Program, University of Toronto, and Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada. 2. The Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada; McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. 3. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 4. The Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada. 5. The Toronto Congenital Cardiac Centre for Adults & Division of Cardiology in the Department of Medicine, University Health Network, Toronto, Ontario, Canada. Electronic address: candice.silversides@uhn.ca. 6. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; The Toronto Congenital Cardiac Centre for Adults & Division of Cardiology in the Department of Medicine, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada; The Dalglish Family Hearts and Minds Clinic for 22q11.2 Deletion Syndrome, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: anne.bassett@utoronto.ca.
Abstract
BACKGROUND: Transposition of the great arteries (TGA) is an uncommon but severe congenital heart malformation of unknown etiology. Rare copy number variations (CNVs) have been implicated in other, more common conotruncal heart defects like tetralogy of Fallot (TOF), but there are as yet no CNV studies dedicated to TGA. METHODS: Using high-resolution genome-wide microarrays and rigorous methods, we investigated CNVs in a group of prospectively recruited adults with TGA (n=101) from a single center. We compared rare CNV burden to well-matched cohorts of controls and TOF cases, adjudicating rarity using 10,113 independent population-based controls and excluding all subjects with 22q11.2 deletions. We identified candidate genes for TGA based on rare CNVs that overlapped the same gene in unrelated individuals, and pre-existing evidence suggesting a role in cardiac development. RESULTS: The TGA group was significantly enriched for large rare CNVs (2.3-fold increase, p=0.04) relative to controls, to a degree comparable with the TOF group. Extra-cardiac features were not reliable predictors of rare CNV burden. Smaller rare CNVs helped to narrow critical regions for conotruncal defects at chromosomes 10q26 and 13q13. Established and novel candidate susceptibility genes identified included ACKR3, IFT57, ITGB8, KL, NF1, NKX1-2, RERE, SLC8A1, SOX18, and ULK1. CONCLUSIONS: These data demonstrate a genome-wide role for rare CNVs in genetic risk for TGA. The findings provide further support for a genetically-related spectrum of congenital heart disease that includes TGA and TOF.
BACKGROUND: Transposition of the great arteries (TGA) is an uncommon but severe congenital heart malformation of unknown etiology. Rare copy number variations (CNVs) have been implicated in other, more common conotruncal heart defects like tetralogy of Fallot (TOF), but there are as yet no CNV studies dedicated to TGA. METHODS: Using high-resolution genome-wide microarrays and rigorous methods, we investigated CNVs in a group of prospectively recruited adults with TGA (n=101) from a single center. We compared rare CNV burden to well-matched cohorts of controls and TOF cases, adjudicating rarity using 10,113 independent population-based controls and excluding all subjects with 22q11.2 deletions. We identified candidate genes for TGA based on rare CNVs that overlapped the same gene in unrelated individuals, and pre-existing evidence suggesting a role in cardiac development. RESULTS: The TGA group was significantly enriched for large rare CNVs (2.3-fold increase, p=0.04) relative to controls, to a degree comparable with the TOF group. Extra-cardiac features were not reliable predictors of rare CNV burden. Smaller rare CNVs helped to narrow critical regions for conotruncal defects at chromosomes 10q26 and 13q13. Established and novel candidate susceptibility genes identified included ACKR3, IFT57, ITGB8, KL, NF1, NKX1-2, RERE, SLC8A1, SOX18, and ULK1. CONCLUSIONS: These data demonstrate a genome-wide role for rare CNVs in genetic risk for TGA. The findings provide further support for a genetically-related spectrum of congenital heart disease that includes TGA and TOF.
Authors: Chunjiang He; Hanyang Hu; Kitchener D Wilson; Haodi Wu; Jing Feng; Siyu Xia; Jared Churko; Kun Qu; Howard Y Chang; Joseph C Wu Journal: Circ Cardiovasc Genet Date: 2016-02-19
Authors: Miriam S Reuter; Rebekah Jobling; Rajiv R Chaturvedi; Roozbeh Manshaei; Gregory Costain; Tracy Heung; Meredith Curtis; S Mohsen Hosseini; Eriskay Liston; Chelsea Lowther; Erwin Oechslin; Heinrich Sticht; Bhooma Thiruvahindrapuram; Spencer van Mil; Rachel M Wald; Susan Walker; Christian R Marshall; Candice K Silversides; Stephen W Scherer; Raymond H Kim; Anne S Bassett Journal: Genet Med Date: 2018-09-20 Impact factor: 8.822
Authors: Doris Škorić-Milosavljević; Rafik Tadros; Fernanda M Bosada; Federico Tessadori; Alex V Postma; Connie R Bezzina; Jan Hendrik van Weerd; Odilia I Woudstra; Fleur V Y Tjong; Najim Lahrouchi; Fanny Bajolle; Heather J Cordell; A J Agopian; Gillian M Blue; Daniela Q C M Barge-Schaapveld; Marc Gewillig; Christoph Preuss; Elisabeth M Lodder; Phil Barnett; Aho Ilgun; Leander Beekman; Karel van Duijvenboden; Regina Bokenkamp; Martina Müller-Nurasyid; Hubert W Vliegen; Thelma C Konings; Joost P van Melle; Arie P J van Dijk; Roland R J van Kimmenade; Jolien W Roos-Hesselink; Gertjan T Sieswerda; Folkert Meijboom; Hashim Abdul-Khaliq; Felix Berger; Sven Dittrich; Marc-Phillip Hitz; Julia Moosmann; Frank-Thomas Riede; Stephan Schubert; Pilar Galan; Mark Lathrop; Hans M Munter; Ammar Al-Chalabi; Christopher E Shaw; Pamela J Shaw; Karen E Morrison; Jan H Veldink; Leonard H van den Berg; Sylvia Evans; Marcelo A Nobrega; Ivy Aneas; Milena Radivojkov-Blagojević; Thomas Meitinger; Erwin Oechslin; Tapas Mondal; Lynn Bergin; John F Smythe; Luis Altamirano-Diaz; Jane Lougheed; Berto J Bouma; Marie-A Chaix; Jennie Kline; Anne S Bassett; Gregor Andelfinger; Roel L F van der Palen; Patrice Bouvagnet; Sally-Ann B Clur; Jeroen Breckpot; Wilhelmina S Kerstjens-Frederikse; David S Winlaw; Ulrike M M Bauer; Seema Mital; Elizabeth Goldmuntz; Bernard Keavney; Damien Bonnet; Barbara J Mulder; Michael W T Tanck; Jeroen Bakkers; Vincent M Christoffels; Cornelis J Boogerd Journal: Circ Res Date: 2021-12-10 Impact factor: 17.367
Authors: Harald Lahm; Meiwen Jia; Martina Dreßen; Felix Wirth; Nazan Puluca; Ralf Gilsbach; Bernard D Keavney; Julie Cleuziou; Nicole Beck; Olga Bondareva; Elda Dzilic; Melchior Burri; Karl C König; Johannes A Ziegelmüller; Claudia Abou-Ajram; Irina Neb; Zhong Zhang; Stefanie A Doppler; Elisa Mastantuono; Peter Lichtner; Gertrud Eckstein; Jürgen Hörer; Peter Ewert; James R Priest; Lutz Hein; Rüdiger Lange; Thomas Meitinger; Heather J Cordell; Bertram Müller-Myhsok; Markus Krane Journal: J Clin Invest Date: 2021-01-19 Impact factor: 14.808